Cadre Holdings, Inc. (CDRE) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 76.92%. A quarter ago, it was expected that this company would post earnings of $0.48 per share when it actually produced earnings of $0.32, delivering a surprise of -33.33%.Over the last four quarters, the co ...

Coty (COTY) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -80%. A quarter ago, it was expected that this beauty products company would post earnings of $0.22 per share when it actually produced earnings of $0.11, delivering a surprise of -50%.Over the last four quarters, the company ...

Arcosa (ACA) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.73 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 68.97%. A quarter ago, it was expected that this provider of infrastructure-related products and services would post earnings of $0.79 per share when it actually produced earnings of $0.46, delivering a surprise of -41.77%.O ...

Kulicke and Soffa (KLIC) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of $0.19. This compares to loss of $0.95 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -373.68%. A quarter ago, it was expected that this semiconductor equipment maker would post earnings of $0.28 per share when it actually produced earnings of $0.37, delivering a surprise of 32.14%.Over the last four quarters, the ...

Voya Financial (VOYA) came out with quarterly earnings of $2.15 per share, beating the Zacks Consensus Estimate of $1.59 per share. This compares to earnings of $1.88 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 35.22%. A quarter ago, it was expected that this retirement, investment and insurance company would post earnings of $0.71 per share when it actually produced earnings of $1.50, delivering a surprise of 111.27%.Over ...

公司业绩表现 - 公司季度每股收益达到盈亏平衡 超出Zacks共识预期的每股亏损005美元 上年同期为每股亏损003美元 经非经常性项目调整后 本季度盈利超出预期100% [1] - 上一季度公司实际每股收益018美元 超出预期014美元 盈利超预期2857% [1] - 过去四个季度中 公司四次超出共识EPS预期 季度营收达13642百万美元 超出共识预期241% 上年同期营收为11402百万美元 过去四个季度中三次超出营收预期 [2] 股价与市场表现 - 公司股价年初至今下跌13% 表现优于同期标普500指数39%的跌幅 [3] - 当前Zacks评级为4级(卖出) 预计短期内股价将弱于大盘 主要因盈利预期修订趋势不利 [6] 未来盈利预期 - 下一季度共识EPS预期为003美元 营收预期14787百万美元 当前财年共识EPS预期016美元 营收预期61945百万美元 [7] - 盈利预期修订趋势对短期股价走势具有强相关性 投资者可追踪Zacks评级工具获取修订动态 [5] 行业状况 - 公司所属的网络安全行业在Zacks行业排名中处于后31%分位 研究表明前50%行业表现是后50%的两倍以上 [8] - 同业公司Fortinet预计将于5月7日公布季度业绩 预期每股收益053美元 同比增长233% 过去30天EPS预期下调02% 预期营收154十亿美元 同比增长135% [9][10]

NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Integra and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On ...

Myriad Genetics (MYGN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40%. A quarter ago, it was expected that this molecular diagnostic company would post earnings of $0.03 per share when it actually produced earnings of $0.03, delivering no surprise.Over the last four quarters, the company ...

财务表现 - 公司季度每股亏损3.42美元，远低于Zacks一致预期的盈利0.35美元，同比由盈转亏（上年同期盈利0.73美元）[1] - 季度营收7.4486亿美元，超出预期6.68%，同比增长80.1%（上年同期4.1346亿美元）[2] - 过去四个季度中，公司两次超出每股收益预期，三次超出营收预期[2] 市场反应 - 年初至今股价累计下跌47.6%，显著跑输标普500指数（-3.9%）[3] - 当前Zacks评级为"持有"，预计短期表现与市场持平[6] 未来展望 - 下季度共识预期为每股收益2.27美元，营收7.3292亿美元；本财年预期每股收益8.08美元，营收30.2亿美元[7] - 行业排名方面，医疗-生物医学与遗传学行业位列Zacks行业前31%，历史数据显示前50%行业表现优于后50%行业超2倍[8] 同业比较 - 同业公司Cartesian Therapeutics预计季度每股亏损0.61美元，同比改善69%，营收预期50万美元（同比下滑91.4%）[9]

Grocery Outlet Holding Corp. (GO) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 85.71%. A quarter ago, it was expected that this supermarket company selling discount, overstocked and closeout products would post earnings of $0.17 per share when it actually produced earnings of $0.15 ...